NEW & HOT

Lucid and Bolt Partner to Deploy 25,000 Autonomous Electric Vehicles Across Europe EPA Formally Finalizes Repeal of Power Plant Carbon Capture and Greenhouse Gas Mandates Congress Overwhelmingly Passes Landmark Bipartisan Sanctions Targeting Shadow Fleet Oil Networks AI Leaders Urge Coordinated Pacing and Independent Safety Audits for Frontier Models Global Oil Prices Surpass $100 as Saudi Pipeline Outage Constrains Supply European Commission and Telecom Leaders Launch EURO-3C Sovereign Cloud and AI Infrastructure Allianz Backs Scaleup Europe Fund to Accelerate European AI and Quantum Champions European Union and Canada Sign Strategic Bilateral Alliance on Critical Minerals and Energy Resilience Lucid and Bolt Partner to Deploy 25,000 Autonomous Electric Vehicles Across Europe EPA Formally Finalizes Repeal of Power Plant Carbon Capture and Greenhouse Gas Mandates Congress Overwhelmingly Passes Landmark Bipartisan Sanctions Targeting Shadow Fleet Oil Networks AI Leaders Urge Coordinated Pacing and Independent Safety Audits for Frontier Models Global Oil Prices Surpass $100 as Saudi Pipeline Outage Constrains Supply European Commission and Telecom Leaders Launch EURO-3C Sovereign Cloud and AI Infrastructure Allianz Backs Scaleup Europe Fund to Accelerate European AI and Quantum Champions European Union and Canada Sign Strategic Bilateral Alliance on Critical Minerals and Energy Resilience

Topic

#Nephrology

Clinical research scientist with micropipette beside kidney health diagnostic ultrasound monitor, medical tablets, and stethoscope

health

FDA Expands Approval of Kerendia to Treat Chronic Kidney Disease in Patients with Type 1 Diabetes

The U.S. Food and Drug Administration today expanded the approved indication for Kerendia (finerenone) to include adult patients with chronic kidney disease associated with type 1 diabetes, following positive outcomes from the pivotal Phase 3 FINE-ONE clinical trial.

Jerry Vasoya ·17 Sep 2026 ·4 min read